SkinBioTherapeutics plc (AIM: SBTX)
London
· Delayed Price · Currency is GBP · Price in GBX
17.00
+1.00 (6.25%)
Dec 2, 2024, 11:56 AM GMT+1
SkinBioTherapeutics Balance Sheet
Financials in millions GBP. Fiscal year is July - June.
Millions GBP. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | 2018 - 2016 |
Cash & Equivalents | 2.84 | 1.31 | 1.8 | 4.61 | 2.16 | 3.12 | Upgrade
|
Cash & Short-Term Investments | 2.84 | 1.31 | 1.8 | 4.61 | 2.16 | 3.12 | Upgrade
|
Cash Growth | 270.84% | -27.32% | -60.85% | 113.51% | -30.91% | -1.82% | Upgrade
|
Accounts Receivable | 0.16 | 0 | 0 | - | - | - | Upgrade
|
Other Receivables | 0.24 | 0.3 | 0.33 | 0.21 | 0.14 | 0.29 | Upgrade
|
Receivables | 0.4 | 0.3 | 0.33 | 0.21 | 0.14 | 0.29 | Upgrade
|
Inventory | 0.05 | 0.03 | 0.12 | - | - | - | Upgrade
|
Prepaid Expenses | - | 0.07 | 0.08 | 0.24 | 0.05 | 0.17 | Upgrade
|
Other Current Assets | -0 | - | - | - | - | - | Upgrade
|
Total Current Assets | 3.29 | 1.72 | 2.33 | 5.06 | 2.35 | 3.58 | Upgrade
|
Property, Plant & Equipment | 0.16 | 0.17 | 0.13 | 0.14 | 0 | 0.01 | Upgrade
|
Other Intangible Assets | 0.76 | 0.7 | 0.63 | 0.53 | 0.42 | 0.35 | Upgrade
|
Total Assets | 4.21 | 2.59 | 3.08 | 5.73 | 2.77 | 3.93 | Upgrade
|
Accounts Payable | 0.46 | 0.19 | 0.07 | 0.08 | 0.14 | 0.06 | Upgrade
|
Accrued Expenses | - | 0.24 | 0.37 | 0.28 | 0.15 | 0.05 | Upgrade
|
Current Portion of Leases | 0.04 | 0.03 | 0.03 | 0.03 | - | - | Upgrade
|
Current Income Taxes Payable | - | 0.06 | 0.03 | 0.02 | 0.02 | 0.02 | Upgrade
|
Other Current Liabilities | - | 0 | 0.01 | 0 | 0 | 0 | Upgrade
|
Total Current Liabilities | 0.5 | 0.53 | 0.51 | 0.4 | 0.3 | 0.12 | Upgrade
|
Long-Term Leases | 0.06 | 0.07 | 0.1 | 0.11 | - | - | Upgrade
|
Total Liabilities | 0.56 | 0.6 | 0.61 | 0.52 | 0.3 | 0.12 | Upgrade
|
Common Stock | 1.9 | 1.73 | 1.57 | 1.57 | 1.28 | 1.28 | Upgrade
|
Additional Paid-In Capital | 13.77 | 10.95 | 8.76 | 8.76 | 4.92 | 4.92 | Upgrade
|
Retained Earnings | -12.46 | -11.12 | -8.29 | -5.5 | -4.14 | -2.64 | Upgrade
|
Comprehensive Income & Other | 0.44 | 0.44 | 0.44 | 0.38 | 0.4 | 0.25 | Upgrade
|
Shareholders' Equity | 3.65 | 1.99 | 2.48 | 5.22 | 2.47 | 3.81 | Upgrade
|
Total Liabilities & Equity | 4.21 | 2.59 | 3.08 | 5.73 | 2.77 | 3.93 | Upgrade
|
Total Debt | 0.1 | 0.1 | 0.13 | 0.14 | - | - | Upgrade
|
Net Cash (Debt) | 2.74 | 1.21 | 1.68 | 4.47 | 2.16 | 3.12 | Upgrade
|
Net Cash Growth | 317.91% | -27.78% | -62.48% | 107.04% | -30.91% | -1.82% | Upgrade
|
Net Cash Per Share | 0.02 | 0.01 | 0.01 | 0.03 | 0.02 | 0.03 | Upgrade
|
Filing Date Shares Outstanding | 190.36 | 173.14 | 156.78 | 156.78 | 128.08 | 128.08 | Upgrade
|
Total Common Shares Outstanding | 190.36 | 173.14 | 156.78 | 156.78 | 128.08 | 128.08 | Upgrade
|
Working Capital | 2.79 | 1.19 | 1.82 | 4.66 | 2.04 | 3.46 | Upgrade
|
Book Value Per Share | 0.02 | 0.01 | 0.02 | 0.03 | 0.02 | 0.03 | Upgrade
|
Tangible Book Value | 2.89 | 1.29 | 1.85 | 4.69 | 2.05 | 3.46 | Upgrade
|
Tangible Book Value Per Share | 0.02 | 0.01 | 0.01 | 0.03 | 0.02 | 0.03 | Upgrade
|
Machinery | - | - | - | - | 0.01 | 0.01 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.